| For: | Zhu Q, Gao BQ, Zhang JF, Shi LP, Zhang GQ. Successful treatment of lichen amyloidosis coexisting with atopic dermatitis by dupilumab: Four case reports. World J Clin Cases 2023; 11(11): 2549-2558 [PMID: 37123319 DOI: 10.12998/wjcc.v11.i11.2549] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i11/2549.htm |
| Number | Citing Articles |
| 1 |
Benedetta Tirone, Gerardo Cazzato, Francesca Ambrogio, Caterina Foti, Marco Bellino. Lichen Amyloidosis in an Atopic Patient Treated with Dupilumab: A New Therapeutic Option. Diseases 2024; 12(5) doi: 10.3390/diseases12050094
|
| 2 |
Feiying Guo, Huajie Zhong, Yuan Wu, Xue Xu, Jiarong Tan, Qiang Zhou, Shunli Tang. Dupilumab for treatment of primary cutaneous amyloidosis in adults: two case reports and literature review. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1485079
|
| 3 |
Oksana A. Bitkina, Vera S. Murashova, Irina V. Temnova, Elena N. Derpaluk, Elizaveta V. Bitkina. Development of amyloid lichen in a patient with atopic dermatitis. Vestnik dermatologii i venerologii 2026; 101(6) doi: 10.25208/vdv16893
|
| 4 |
Thiago Lenoir da Silva, Gleison Vieira Duarte. Remission of refractory lichen amyloidosis with baricitinib. Anais Brasileiros de Dermatologia 2026; 101(3) doi: 10.1016/j.abd.2026.501363
|
| 5 |
Wenxin Zhang, Dandan Mao, Cheng Zhou, Guangdong Wen. Improvement of Low-Dose Abrocitinib-Resistant Lichen Amyloidosis with Dupilumab: Two Case Reports. Clinical, Cosmetic and Investigational Dermatology 2025; doi: 10.2147/CCID.S555311
|
| 6 |
Gustavo Freitas, Albert E. Zhou, Katalin Ferenczi. Cobblestoning Monomorphic Papules of the Lower Extremities. JAMA Dermatology 2026; doi: 10.1001/jamadermatol.2026.0280
|
| 7 |
Qin-Xiao Wang, Qian Ye, Kai-Yi Zhou, Si-Yu Luo, Sheng Fang. Systematic review and meta-analysis of treatments and outcomes in primary localized cutaneous amyloidosis. Clinical and Experimental Dermatology 2025; 50(7) doi: 10.1093/ced/llaf081
|
| 8 |
Sohrab Elahwiesy, Franziska Jochims, Manfred Kunz, Susann Forkel, Jan‐Christoph Simon, Benjamin Klein. Successful Treatment of Refractory Lichen Amyloidosus With Dupilumab. JEADV Clinical Practice 2026; doi: 10.1002/jvc2.70386
|
| 9 |
M. Amiot, I. Moulonguet. Amylose papuleuse (« lichen amyloïde »). Annales de Dermatologie et de Vénéréologie - FMC 2024; 4(7) doi: 10.1016/j.fander.2023.10.014
|
| 10 |
Alexandru-Florin Florescu, Oana-Claudia Sima, Claudiu Nistor, Mihai-Lucian Ciobica, Mihai Costachescu, Mihaela Stanciu, Denisa Tanasescu, Florina Ligia Popa, Mara Carsote. Endocrine Perspective of Cutaneous Lichen Amyloidosis: RET-C634 Pathogenic Variant in Multiple Endocrine Neoplasia Type 2. Clinics and Practice 2024; 14(6) doi: 10.3390/clinpract14060179
|
| 11 |
Seitaro Nakagawa, Ikuko Ueda-Hayakawa, Manabu Fujimoto. Nemolizumab for treatment of lichen amyloidosis. JAAD Case Reports 2025; 63 doi: 10.1016/j.jdcr.2025.06.010
|
| 12 |
Rachel L. Ziebart, Jason C. Sluzevich. Remission of lichen amyloidosis achieved with upadacitinib: A case report. JAAD Case Reports 2025; 65 doi: 10.1016/j.jdcr.2025.06.061
|
| 13 |
Yizhen Zhang, Dawei Huang, Yunlu Gao. Case report: Abrocitinib: a potential therapeutic option for lichen amyloidosis associated with atopic dermatitis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1477664
|
| 14 |
Rucha Janodia, Robert A. Schwartz. Cutaneous Amyloidosis: An Updated Approach Focusing on Macular Amyloidosis. Dermatology 2026; 242(3) doi: 10.1159/000550263
|
| 15 |
Pan Zou, Yuxin Du, Yuchun Cao, Hongxiang Chen, Yi Duan. Treatment of primary cutaneous amyloidosis with tofacitinib: preliminary observations from a single-arm clinical trial. Clinical and Experimental Dermatology 2025; 51(1) doi: 10.1093/ced/llaf364
|
| 16 |
Kaito Iwama, Daiki Rokunohe, Kazuhito Kogawa, Eijiro Akasaka. Rapid clinical response to nemolizumab in a patient with lichen amyloidosis. JAAD Case Reports 2026; doi: 10.1016/j.jdcr.2026.05.021
|